Abstract
HIV-1 integrase (HIV-IN) is a well-validated antiviral drug target catalyzing a multistep reaction to incorporate the HIV-1 provirus into the genome of the host cell. Small molecule inhibitors of HIV-1 integrase that specifically target the strand transfer step have demonstrated efficacy in the suppression of virus propagation. However, only few specific strand transfer inhibitors have been identified to date, and the need to screen for novel compound scaffolds persists. Here, the authors describe 2 homogeneous time-resolved fluorescent resonance energy transfer-based assays for the measurement of HIV-1 integrase 3′-processing and strand transfer activities. Both assays were optimized for high-throughput screening formats, and a diverse library containing more than 1 million compounds was screened in 1536-well plates for HIV-IN strand transfer inhibitors. As a result, compounds were found that selectively affect the enzymatic strand transfer reaction over 3′ processing. Moreover, several bioactive molecules were identified that inhibited HIV-1 reporter virus infection in cellular model systems. In conclusion, the assays presented herein have proven their utility for the identification of mechanistically interesting and biologically active inhibitors of HIV-1 integrase that hold potential for further development into potent antiviral drugs. © 2005 The Society for Biomolecular Screening.
Author supplied keywords
Cite
CITATION STYLE
Wang, Y., Klock, H., Yin, H., Wolff, K., Bieza, K., Niswonger, K., … Brinker, A. (2005). Homogeneous high-throughput screening assays for HIV-1 integrase 3′-processing and strand transfer activities. Journal of Biomolecular Screening, 10(5), 456–462. https://doi.org/10.1177/1087057105275212
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.